Research Papers

25 of 428 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Lipid Horizons: Recent Advances and Future Prospects in LBDDS for Oral Administration of Antihypertensive Agents.
Preeti; Sambhakar S; Malik R; Bhatia S; Harrasi AA; Saharan R; Aggarwal G; Kumar S; Sehrawat R; Rani C.
Int J Hypertens (Unknown)
Published: 2024
2/6 Transparent
Da-Chuan-Xiong Decoction Ameliorates Sodium Sensitivity and Plasma Norepinephrine via Attenuation of Brain Oxidative St…
Zhang Q; Li H; Zhao S; Li F; Tan Y.
Int J Hypertens (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Evaluation of Mean Platelet Volume in Children with Hypertension.
Yildiz I; Kizilca O.
Int J Hypertens (Unknown)
Published: 2023
2/6 Transparent
miR-145 Alleviates Smooth Muscle Cell Phenotype Transition via ADAM17-Mediated ACE2 Shedding.
Wen J; Tang B; Guo L; Chen W; Tang X.
Int J Hypertens (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Comorbidity of Anxiety and Hypertension: Common Risk Factors and Potential Mechanisms.
Qiu T; Jiang Z; Chen X; Dai Y; Zhao H.
Int J Hypertens (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Intensive Blood Pressure Control and Diabetes Mellitus Incidence for Patients with Impaired Fasting Glucose: A Secondar…
Lin B; Liu X; Yao S; Pan Z.
Int J Hypertens (Unknown)
Published: 2023
4/6 Transparent
Registered Funding Declared
Efficacy and Safety of Eplerenone for Treating Chronic Kidney Disease: A Meta-Analysis.
Hu H; Cao M; Sun Y; Jin X; Zhao X; Cong X.
Int J Hypertens (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Evaluation of Arterial Stiffness and Its Relation to Innovative Anthropometric Indices in Persian Adults.
Ataee Z; Aghaee A; Sobhani SR; Ebrahimi Miandehi E; Pirzadeh P; Alinezhad-Namaghi M; Eslami S; Sobhani S.
Int J Hypertens (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
The Association between Hypertension and Insomnia: A Bidirectional Meta-Analysis of Prospective Cohort Studies.
Liu D; Yu C; Huang K; Thomas S; Yang W; Liu S; Kuang J.
Int J Hypertens (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Prevalence and Clinical Characteristics including Patterns of Antihypertensive Drug Administration of the Different Hom…
Chotruangnapa C; Thammarux T; Thongdang P.
Int J Hypertens (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Exercise-Induced Excessive Blood Pressure Elevation Is Associated with Cardiac Dysfunction in Male Patients with Essent…
Xia B; Cao P; Zhang L; Huang H; Li R; Yin X.
Int J Hypertens (Unknown)
Published: 2022
4/6 Transparent
Registered Funding Declared
Preference for Stronger Taste Associated with a Higher Risk of Hypertension: Evidence from a Cross-Sectional Study in N…
Liu H; Wang Y; Zhang B; Huo Y; Cao S; Liu J; Zeng L; Yan H; Dang S; Mi B.
Int J Hypertens (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Influence of AGTR1 and ABCB1 Gene Polymorphism on the Curative Effect of Irbesartan.
Wang Q; You L; Li Z; Zhang L; Li X; Yang X.
Int J Hypertens (Unknown)
Published: 2022
2/6 Transparent
Syndecan-4 is More Sensitive in Detecting Hypertensive Left Ventricular Diastolic Dysfunction in 2K2C Rats.
Dai W; Liu Y; Yao F; Li W; Liu J; Li C; Liu D.
Int J Hypertens (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Trajectories of Blood Pressure in Patients with Established Coronary Artery Disease over 20 years.
Jankowski P; Kozieł P; Bilo G; Pinkas J; Czarnecka D; Kawecka-Jaszcz K; Pająk A.
Int J Hypertens (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Emergent Anthropometric Indices in Differential Prediction of Prehypertension and Hypertension in Mexican Population: R…
Zaragoza-García O; Gutiérrez-Pérez IA; Delgado-Floody P; Parra-Rojas I; Jerez-Mayorga D; Campos-Jara C; Guzmán-Guzmán IP.
Int J Hypertens (Unknown)
Published: 2022
2/6 Transparent
Gender Differences in Cardiovascular Risk Factors, Clinical Presentation, and Outcome of Patients Admitted with a Hyper…
Nkoke C; Jingi AM; Noubiap JJ; Teuwafeu D; Nkouonlack C; Gobina R; Djibrilla S; Abas A; Dzudie A.
Int J Hypertens (Unknown)
Published: 2022
2/6 Transparent
The Value of Four Anthropometric Indicators for Identifying Left Ventricular Hypertrophy in Chinese Hypertensive Patien…
Cheng B; Lu N; Song G; Qiu J; Dong J; Cai S; Su Y; Sun J; Zhang A; Bao Q; Li M; Ma S; Zhang Y; Zhu P; Wang S.
Int J Hypertens (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Combination of <i>Oxalobacter Formigenes</i> and <i>Veillonella Parvula</i> in Gastrointestinal Microbiota Related to B…
Li X; Wang L; Ma S; Lin S; Wang C; Wang H.
Int J Hypertens (Unknown)
Published: 2022
3/6 Transparent
Data
Comparative Efficacy of Antihypertensive Agents in Flow-Mediated Vasodilation of Patients with Hypertension: Network Me…
Ding H; Liu S; Zhao KX; Pu J; Xie YF; Zhang XW.
Int J Hypertens (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Factors Affecting ICU Stay and Length of Stay in the ICU in Patients with HELLP Syndrome in a Tertiary Referral Hospita…
Ağaçayak E; Bugday R; Peker N; Deger U; Ölmez Kavak G; Evsen MS; Gul T.
Int J Hypertens (Unknown)
Published: 2022
2/6 Transparent
The Association of Serum Anti-Lysosomal-Associated Membrane Protein-2 Antibody with Vasculitis Combined with Hypertensi…
Zhu B; Cai X; Zhu Q; Wu T; Liu S; Liu S; Hong J; Li N.
Int J Hypertens (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Association of AGTR1 A1166C and CYP2C9∗3 Gene Polymorphisms with the Antihypertensive Effect of Valsartan.
Liu Y; Kong X; Jiang Y; Zhao M; Gao P; Cong X; Cao Y; Ma L.
Int J Hypertens (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Prevalence of Cardiovascular Disease Risk Factors in the Women Population Covered by Health Centers in Ardabil.
Avesta L; Rasoolzadeh S; Naeim M; Kamran A.
Int J Hypertens (Unknown)
Published: 2022
2/6 Transparent
Skipping Breakfast Is Associated with Hypertension in Adults: A Meta-Analysis.
Li Z; Li H; Xu Q; Long Y.
Int J Hypertens (Unknown)
Published: 2022
2/6 Transparent